SEC Filings TLDR

On October 27, 2025, John J Corkrean, an officer at H.B. Fuller Company, exercised employee stock options for 14,222 shares of common stock. The transaction was executed through a broker payment for a cashless exercise, with the shares being sold on the same day. The aggregate market value of the shares sold was $857,7...

The filing details the securities transactions of Tan Kwang Hooi, an officer of FLEX LTD. The notice date for the filing is October 27, 2025, and the plan adoption date is December 9, 2024. The securities to be sold include 8,980 common shares acquired on June 14, 2024, and 3,520 common shares acquired on June 11, 2024...

Anil R Chitkara, an officer at Evolv Technologies Holdings, Inc., has exercised stock options for 120,000 common shares on October 27, 2025. The shares were acquired from the issuer, and the transaction was a cash payment. Additionally, Chitkara sold 240,000 common shares on October 24, 2025, generating gross proceeds ...

David Fisher, an officer at Enova International, has filed a notice regarding the sale of securities under Rule 144. The filing details the sale of 6,000 common shares acquired through stock options on February 12, 2019, with an aggregate market value of $720,000. Additionally, Fisher reported multiple sales of Enova I...

The filing details the equity transactions of Mark W. Begor, an officer and director of Equifax Inc. The transactions include the sale of 21,386 shares from the Mark W. Begor Two Year Equifax June 2025 Grat trust account, where Begor is a trustee and account stakeholder. Additionally, the filing reports the vesting of ...

The filing discloses the sale of 4,925 shares of common stock by Jamil Farshchi, an officer of Equifax Inc. The shares were acquired through an option granted on February 21, 2020, and were sold on October 27, 2025. The aggregate market value of the shares sold was $1,176,779.50. The transaction was executed through Fi...

Molly Campbell, a director of East West Bancorp Inc, has filed a Form 144 notice indicating her intention to sell 3,155 shares of the company's common stock. The shares were acquired on August 15, 2017, through equity compensation for services rendered. The planned sale is expected to occur on October 27, 2025, with an...

Douglas Paul Krause, an officer of East West Bancorp Inc, has filed a Form 144 with the SEC indicating his intent to sell 10,000 shares of common stock. The shares were acquired through open market purchases and compensation, with 3,000 shares acquired on October 1, 2005, and 7,000 shares acquired on March 4, 2025. The...

Jeffrey Jacobs, an officer of Dayforce, Inc., has filed a Form 144 indicating his intention to sell 353 shares of the company's common stock. The shares were acquired as restricted stock on May 8, 2023, and May 8, 2022. The planned sale is expected to occur around October 27, 2025, with an aggregate market value of $24...

John J. Lupica, an officer of Chubb Ltd, has filed a Form 144 indicating his intention to sell 23,698 shares of Chubb Ltd common stock. The shares were acquired through options granted on February 25, 2016, and are set to be sold on October 27, 2025. The aggregate market value of the shares to be sold is approximately ...

Mario Alberto Accardi, an officer of Centessa Pharmaceuticals plc, has filed a Form 144 to report transactions under a Rule 10b5-1 trading plan. The plan, adopted on February 14, 2025, involves the sale of 8,000 common shares acquired as Founders Shares on January 2, 2020. The approximate sale date is October 27, 2025,...

Matthew Szot, an officer of Cadrenal Therapeutics Inc., has reported multiple transactions involving the sale of common stock under a 10b5-1 trading plan. The transactions occurred between August 27, 2025, and October 24, 2025, with the largest single transaction involving the sale of 10,900 shares for $153,182.06 on S...

Quang X. Pham, an officer of Cadrenal Therapeutics, Inc., has filed a notice of planned sale of 1,315 shares of common stock, acquired as Founders Shares on January 25, 2022. The sale is scheduled for October 27, 2025, with an aggregate market value of $18,396.86. Additionally, Pham has engaged in multiple transactions...

Wendell Wierenga, a director at Cytokinetics, Incorporated, has filed a Form 144 with the SEC detailing his plan to sell 4,375 shares of common stock acquired through the exercise of stock options. The shares were acquired on October 27, 2025, and the sale is planned for the same date. The aggregate market value of the...

This SEC filing discloses Gil Shwed, an officer of Check Point Software Technologies Ltd., intends to sell 66,467 common shares pursuant to a Rule 10B5-1 trading plan adopted on March 7, 2025. The plan details systematic sales between July 28, 2025, and October 27, 2025, with aggregate proceeds exceeding $127.5 million...

Plusener S.A., a 10% stockholder of Central Puerto S.A., has filed a notice of its intention to sell 3,835,445 common shares of Central Puerto S.A. The shares were acquired as a Pre-IPO investment on February 2, 2017. The aggregate market value of the shares to be sold is approximately $3,788,601.81, based on the closi...

Thomas M. Lo, an officer at Cathay General Bancorp, has reported the lapse of restricted stock. The securities, consisting of 1,000 shares of common stock, were acquired on March 16, 2025, and the lapse occurred on the same date. The aggregate market value of the securities at the time of the notice was $46,828. The tr...

Richard D. Fairbank, an officer and director of Capital One Financial Corporation, has filed a Form 144 indicating the sale of 103,486 common shares. The shares were acquired through stock option exercises on 10/27/2025 (53,486 shares) and 07/27/2021 (50,000 shares). The aggregate market value of the shares to be sold ...

Jerry J. Baack, an officer and director of Bridgewater Bancshares Inc, has filed a Form 144 notice indicating his intention to sell 77,097 shares of the company's common stock. The shares were acquired on June 10, 2008, through a private placement. The approximate sale date is set for October 28, 2025, with an aggregat...

Frank McCormick, a director at BridgeBio Pharma, has filed a Form 144 to report his intention to sell shares under a 10b5-1 plan. The plan was adopted on August 28, 2024, and the shares to be sold were acquired on October 1, 2021, as part of a stock bonus. McCormick plans to sell 1641 shares of common stock, with an ag...

Ellen M Zane, a director of Boston Scientific Corp, has filed a Form 144 indicating her intention to sell 9,990 shares of common stock held in the Ellen Zane Family Trust. The shares were acquired through stock grants on May 9, 2020, and May 7, 2021. The planned sale is expected to occur on October 27, 2025, with an ag...

Thomas Unterman, a director of BLACKLINE, INC., has reported the sale of 910 shares of common stock on 10/27/2025, with an aggregate market value of $50,050.00. This sale is part of a plan adopted on 11/21/2024. Additionally, Unterman sold 910 shares on 09/22/2025 and another 910 shares on 08/28/2025, each valued at $5...

Chelsea Grayson, an officer of Beyond Meat Inc, has filed a notice regarding the sale of securities. The filing details the sale of 492 common shares on October 27, 2025, with an aggregate market value of $984. The shares were acquired on May 23, 2024, as vested restricted shares. Additionally, the filing reports three...

Richard M. Schulze, a 10% stockholder of Best Buy Co Inc, has filed a Form 144 indicating the sale of a substantial amount of common stock. The filing, made on behalf of the Richard M. Schulze Revocable Trust, details the sale of 104,313 shares of common stock acquired as Founders Shares on April 18, 1985. The approxim...

Michael Feld, an officer of Becton, Dickinson and Company, has filed a Form 144 notice indicating his intention to sell 57 shares of common stock acquired through Restricted Stock Units. The shares were acquired on August 20, 2025, and the planned sale is expected to occur around October 27, 2025, with an aggregate mar...